Journals / Turkish Journal of Hematology / 2010 / Cilt: 27 - Sayı: 4

Primer hemofagositik lenfohistiositozisli hastaların klinik ve labarotuvar verileri; Türk Histiosit Çalşşma Grubunun retrospektif derlemesi

Clinical and laboratory data of primary hemophagocytic lymphohistiocytosis: A retrospective review of the Turkish Histiocyte Study Group

Pages
257–262
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Triglyceride and total bilirubin levels in the deceased versus surviving group appear to be high (triglyceride: 394±183 mg/dl, 289±7 mg/dl; total bilirubin: 2.7±6.9 mg/dl, 0.5±1.2 mg/ dl, respectively).Conclusion: We concluded that fever, hepatosplenomegaly, anemia, thrombocytopenia, and hyperferritinemia are the most common clinical and laboratory findings in primary HLH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study analyzes the clinical and laboratory findings of children with primary hemophagocytic lymphohistiocytosis (HLH) followed in various referral centers of Turkey.
📊
Key Findings & Data:Results: Age at diagnosis varied from 0.6 to 78 months (median±SD, 16.5±26.1).
💡
Conclusion & Impact:Triglyceride and total bilirubin levels in the deceased versus surviving group appear to be high (triglyceride: 394±183 mg/dl, 289±7 mg/dl; total bilirubin: 2.7±6.9 mg/dl, 0.5±1.2 mg/ dl, respectively).Conclusion: We concluded that fever, hepatosplenomegaly, anemia, thrombocytopenia, and hyperferritinemia are the most common clinical and laboratory findings in primary HLH.
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study analyzes the clinical and laboratory findings of children with primary hemophagocytic lymphohistiocytosis (HLH) followed in various referral centers of Turkey. Materials and Methods: A simple three-page questionnaire prepared by the Turkish Histiocyte Study Group was used for documentation of patient data. Results: Age at diagnosis varied from 0.6 to 78 months (median±SD, 16.5±26.1). Sex distribution was almost equal (F/M=10/12). The frequencies of parental consanguinity and sibling death in the family history were 100% and 81.1%, respectively. The most common clinical findings were hepatomegaly (100%) and fever (95%). The most common laboratory findings were anemia (100%), hyperferritinemia (100%) and thrombocytopenia (90.9%). Triglyceride and total bilirubin levels in the deceased versus surviving group appear to be high (triglyceride: 394±183 mg/dl, 289±7 mg/dl; total bilirubin: 2.7±6.9 mg/dl, 0.5±1.2 mg/ dl, respectively).Conclusion: We concluded that fever, hepatosplenomegaly, anemia, thrombocytopenia, and hyperferritinemia are the most common clinical and laboratory findings in primary HLH. Increased triglyceride and total bilirubin level at the time of diagnosis might be an indicator of poor prognosis in HLH. (Turk J Hematol 2010; 27: 157-62)

Özet

AMAÇ: Primer hemofagositik lenfohistiositoz tanısı ile Türkiye’deki farklı merkezlerde takip edilen hastaların klinik ve laboratuar değerlerini değerlendirmektir. YÖNTEMLER: Hasta verilerinin değerlendirilmesi için Türk Histiosit Çalışma Grubu tarafından düzenlenmiş 3 sayfalık soru formu kullanıldı. BULGULAR: Olguların tanı sırasındaki yaşları 0.6 ile 78 ay arasında idi (median±SD, 16.5±26.1). Cinsiyet dağılımı eşite yakındı (K/E=10/12). Anne-baba akrabalığı ve kardeş ölüm öyküsü oranları sırası ile %100 ve %81.1 idi. Ensık görülen klinik bulgular hepatomegali (%100), ateş (%95), labaratuvar bulguları ise anemi (%100), hiperferritinemi (%100) ve trombositopeniydi (%90.9). Ölen olguların trigliserid ve bilirubin düzeyleri yüksek gibi gözükmekteydi (trigliserid; 394±183 mg/dL, 289±7 mg/dL, total bilirubin; 2.7±6.9 mg/dL, 0.5±1.2 mg/dL) SONUÇ: Ateş, hepatosplenomegali, anemi, hiperferritinemi ve trombositopeni primer HLH'li hastalarda en sık görülen klinik ve labaratuvar bulgulardır. Tanı sırasındaki artmış trigliserid ve bilirubin düzeyleri kötü prognostik belirteç olabilir.

🔖

Cite This Article

FIŞGIN, T., PATIROĞLU, T., ÖZDEMİR, A., CELKAN, T., ÇALIŞKAN, Ü., ERTEM, M., YARALI, H. N., ERDURAN, E., VERGİN, C., CANPOLAT, C., DURU, F., BAY, A., ÖZBAK, N., KARAPINAR, D. Y. (2010). Primer hemofagositik lenfohistiositozisli hastaların klinik ve labarotuvar verileri; Türk Histiosit Çalşşma Grubunun retrospektif derlemesi. Turkish Journal of Hematology, Cilt: 27 - Sayı: 4, 257–262. https://ajindex.com/articles/412954

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31
  2. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:957-9
  3. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachée-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G. Munc13_/4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461-73. 4. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, Kabisch H, Schneppenheim R, Nürnberg P, Janka G, Hennies HC. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005;14:827-34
  4. Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, Al-Manjomi F, Al-Harbi M, Alangari A, Le Deist F, Gennery AR, Prince N, Cariou A, Nitschke P, Blank U, El-Ghazali G, Ménasché G, Latour S, Fischer A, de Saint Basile G. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 2009;119:3765-73
  5. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007;166:95-109
  6. Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, Janka G, Aricò M. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 2001;86:499-503
  7. Henter JI, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22
  8. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006;38:20-31
  9. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31
  10. Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP. Hemophagocytic lymph